AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05650151 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D
Description: 576 000 IU D 5-7 days prior to the surgery and 144 000 IU daily on post-operative day 1-2
Study NCT05650151 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: An equal volume of medium chain triglyceride (MCT, as placebo) to vitamin D 5-7 days prior to the surgery and on the post-operative day 1-2.
Study NCT06504355 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training program incorporating video aerobic exercise, action video game and resistive action video game
Description: Participants in the experimental group participated in three 60-minute training sessions each week for 12 weeks. One of the session was group training. The other two session were individual training. In the group training session, the participants participate in the video aerobic exercise; in the individual sessions, the participants play action and resistive action video games: Fitness Boxing 2 and Adventure Ring-Fit. All participants in the experimental group wore a hear rate monitoring watch so that the researchers make sure that medium level of physical activities was achieved in each session.
Study NCT06143527 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AlloRx
Description: Cultured allogeneic adult umbilical cord derived mesenchymal stem cells
Study NCT04936451 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: TENS (transcutaneous electrical nerve stimulation) ECOMODYN
Description: TENS ECOMODYN® is applied to 4 treatment points, 5 minutes per point 2 times a day for 2 months.~A minimum rest period of 4 hours between 2 sessions on the same point must be respected Stimulation is performed directly with the bipolar probe of the TENS ECOMODYN® device on the painful area by fixed stimulation of 4 active pain points in 77Hz mode.
Study NCT06695975 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Occupational self-analysis
Description: Occupational self analysis program is delivered in group sessions, each session lasting 45 minutes, twice a week. Also Individual sessions are held throughout the program with each participant, with the intention of clarifying certain concepts and resolving specific difficulties that were occurring.The thematic modules worked are 5; occupation-health and difficulty, occupational balance, adaptation strategies to difficulties, social relationships and knowing other realities.~The methodological strategies used to structure the program were the Model of Human Occupation (MOHO) and the See-Judge-Act methodology
Study NCT04898504 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Floxuridine
Description: A laparotomy will be performed and a catheter placed in the hepatic artery Connected to a subcutaneous pump. This pump will be percutaneously filled with Floxuridine 6 times in 2 weeks cycles, alternating with heparin-solution.
Study NCT04898504 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Liver Transplantation
Description: Patients randomized to this arm will be given 2nd line chemotherapy (regimen given at the discression of the treating oncologist) followed by liver-Tx
Study NCT01172249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate + chondroitin sulfate - MANTECORP
Description: 1 capsule three times daily before meals (glucosamine sulfate 500 mg + sodium chondroitin sulfate 400 mg).
Study NCT01172249 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucosamine sulfate + chondroitin sulfate - CONDROFLEX
Description: 1 capsule three times daily before meals (glucosamine sulfate 500 mg + sodium chondroitin sulfate 400 mg).
Study NCT06688890 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surgical hand rub with the reference product; n-propanol 60%.
Description: Propanol hand rub for 3 min. The applied volume of product is sufficient to keep the hand moist for a total time of 3 min, adding as many 3 ml portions as necessary according to EN 12791. According to the EN 1279, the role assigned to each hand (immediate or 3h effect) in the first run is swapped in the subsequent runs.
Study NCT06688890 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surgical hand rub with the product P1; Sorbectol for 1 min.
Description: Sorbectol hand rub for 1 min. The applied volume of product is sufficient to keep the hand moist for a total time of 1 min, adding as many 3 ml portions as necessary according to EN 12791. According to the EN 1279, the role assigned to each hand (immediate or 3h effect) in the first run is swapped in the subsequent runs.
Study NCT06688890 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surgical hand rub with the product P2; Sorbectol for 3 min.
Description: Sorbectol hand rub for 3 min. The applied volume of product is sufficient to keep the hand moist for a total time of 3 min, adding as many 3 ml portions as necessary according to EN 12791. According to the EN 1279, the role assigned to each hand (immediate or 3h effect) in the first run is swapped in the subsequent runs.
Study NCT06688890 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surgical hand rub with the product P3; Sorbectol for 5 min.
Description: Sorbectol hand rub for 5 min. The applied volume of product is sufficient to keep the hand moist for a total time of 5 min, adding as many 3 ml portions as necessary according to EN 12791. According to the EN 1279, the role assigned to each hand (immediate or 3h effect) in the first run is swapped in the subsequent runs.
Study NCT06694532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Description: Comparative study between Hyalgan and Hyorth injectable products in TMJ Disorders by arthrocentesis of 2 syringes device
Study NCT06232837 — intervention group
Intervention type: DEVICE
Intervention: Direct laryngoscopy using Macintosh blade
Description: Patients in operative room requiring direct laryngoscopy for endotracheal intubation
Study NCT06694532 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Syringes
Description: Whilst you are asleep, two small needles will be inserted into the TMJ / Jaw Joint. One of these needles allows sterile saline to be pumped into the joint under pressure whilst the other needle allows the saline to drain out of the joint then injection of the HA injectiable products .
Study NCT06689384 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Taking images from the right lower jaw with an intraoral scanner
Description: The patients' mandibular arches were scanned with 4 different intraoral scanners (IOS) (Trios 3, 3Shape; Primescan, Dentsply; Element 5D, iTero; Lumina, iTero) prior to the procedure, and the obtained digital impressions were stored as a standard tessellation language (STL) file. The 2nd premolar, 1st, and 2nd molar teeth were isolated with a rubber dam (medium; Nic Tone, Manufacturera Dental Continental) to be included in the operation field. Clamps were placed on the 2nd premolar and 2nd molar teeth. Subsequently, the mesh hole area was rescanned starting on the occlusal surface of the second molar, moving toward the occlusal of the first molar to the occlusal of the second premolar, then the buccal surfaces of the second premolar, followed by the first molar and second molar.
Study NCT06689384 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Clamp placement on canine and 2nd molar teeth and rubberdam rubber band insertion
Description: The 2nd premolar, 1st, and 2nd molar teeth were isolated with a rubber dam (medium; Nic Tone, Manufacturera Dental Continental) to be included in the operation field. Clamps were placed on the 2nd premolar and 2nd molar teeth. It was aimed to facilitate the second scanning process by expanding the isolation area to include 3 teeth.~A flowable composite was applied by placing Teflon tape on the occlusal surface of the 1st molar to create a difference in its morphology.
Study NCT06723522 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: HD-tDCS
Description: 2 mA HD-tDCS of right inferior frontal gyrus lasting for 10 days, each stimulation lasted for 20 min, with 30 s of ramp-up and ramp-down before and after the 20-min stimulation, respectively.
Study NCT06723522 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham (No Treatment)
Description: Received 1 min of ramping up/down without experiencing 2 mA HD-tDCS stimulation lasted for 20 min.
Study NCT06732830 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DayDrop Advanced ophthalmic drop
Description: The patient will administer 1 or 2 drops of DayDrop Advanced in each eye 3 times a day for 3 months.
Study NCT06737289 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Surgical Guide
Description: Placing extralarge implats for rahabilitation atrophic maxilla
Study NCT06737289 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Guide
Description: Placing extralarge implats for rahabilitation atrophic maxilla
Study NCT06739330 — intervention group
Intervention type: DEVICE
Intervention: Fibroscan
Description: Fibroscan will be used to assess the stages of fibrosis and steatosis using Dimensional ultrasound TE (transient elastography). Dimensional ultrasound TE (transient elastography) will be used for staging liver fibrosis and steatosis by measuring the velocity of a low frequency (50 Hz) elastic shear wave propagating through the liver.
Study NCT06745115 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood fluorescence metabolite analyzer
Description: This study does not involve Intervention. The fluorescence intensity quantified by the blood fluorescence metabolite analyzer does not affect or interfere with clinical diagnosis and treatment. In both the early and late stages of sepsis, a significant increase in inflammatory free radicals changes the optical properties of the patient's blood, distinguishing it from that of healthy individuals. To explore this phenomenon, 10 cc of fasting blood is drawn from patients who pass our screening criteria. This sample is then centrifuged in accordance with our detailed standard operating procedures to ready it for analysis. Subsequently, the fluorescence intensity of the blood is measured quantitatively using a precisely calibrated blood fluorometer, which is specifically designed to detect subtle variations indicative of both early and late sepsis. This entire process is executed under stringent quality control protocols to ensure the reliability and accuracy of the results.
Study NCT06739239 — intervention group
Intervention type: DEVICE
Intervention: Extra-Vascular Implantable Cardioverter Defibrillator
Description: The pulse generator is implanted along the patient's left midaxillary line, and the lead is positioned substernally.
Study NCT06740552 — intervention group
Intervention type: DRUG
Intervention: Evolocumab
Description: Evolocumab 140mg every two weeks
Study NCT06740552 — intervention group
Intervention type: DRUG
Intervention: Lipid Lowering Medication
Description: Any lipid lowering medication, including statin, ezetimibe, fibrates and etc.
Study NCT06745050 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text message mHealth Evidence-based intervention
Description: MM! includes three messages per week in month one, then two messages per week for the six-month intervention period. Earlier messages include more informational and motivational content, while later messages include more behavioral skills.
Study NCT06744218 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Treatment
Description: Patients who will be assigned to the control group and subjected to standard treatment (usual care at our clinic) will undergo a physiotherapy treatment of 8 in-person sessions for 4 post-operative weeks
Study NCT06744218 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Experimental Treatment
Description: patients who will be assigned to the experimental group and subjected to the experimental treatment will undergo a physiotherapy treatment of 8 sessions in telerehabilitation for 4 post-operative weeks
Study NCT06744296 — intervention group
Intervention type: OTHER
Intervention: Blood Draws and Tissue Sample(s)
Description: All participants on the study, regardless of arm, will be getting blood draws, and tissue samples.
Study NCT06745726 — intervention group
Intervention type: DRUG
Intervention: Zestril
Description: N/A, this is an observational study.
Study NCT06745583 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EI-1071 tablet, oral
Description: Dose: 448.2 mg BID for 28 days
Study NCT06686823 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Education Program
Description: n informative leaflet will promote a healthy lifestyle with WHO guidelines to reduce cognitive decline, recommending a balanced diet, physical activity, social engagement, cognitive games, good sleep, stress management, hydration, and avoiding smoking and excessive alcohol.
Study NCT06686823 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training Program
Description: The cognitive training program (CT) on everyday cognition (EC) will be individualized, with each participant receiving a tailored dossier. The intervention includes four 1-month training periods (P1-P4), each featuring 20 activities, conducted at a rate of 5 activities per week over 4 months.
Study NCT06686381 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Maximum TURBT
Description: Total removal of the bladder tumor through TURBT
Study NCT06686381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy + Immunotherapy Induction
Description: Chemotherapy: DDMVAC (6 cycles) or Gemcitabine-Cisplatin (4 cycles) Immunotherapy: Avelumab (6 cycles)
Study NCT06686381 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Hypofractionated radiotherapy: 20 fractions, 55 Grays
Study NCT06686381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Immunotherapy Maintenance
Description: Maintenance Avelumab every 2 weeks for 12 months
Study NCT06686381 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Watchful waiting with supportive care
Description: 1 year watch and wait
Study NCT06690619 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Maltodextrin
Study NCT06690619 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: 315 mg Alpha-GPC
Description: 350 mg of 90% pure alpha-GPC (315 mg)
Study NCT06690619 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: 630 mg Alpha-GPC
Description: 700 mg of 90% pure alpha-GPC (630 mg)
Study NCT06689306 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 7E learning model
Description: 7E learning model7E learning cycle is a teaching model that encourages students to be active, to think about the findings they obtain, to interpret their findings according to their initial plans and to predict them in new situations. This model provides students with opportunities for discussion and interaction. The model is designed based on constructivist theory. The guiding concept of constructivism is that later learning is greatly influenced by previous knowledge; therefore, learning should be based on the interaction of old and new knowledge. 7E learning cycle model consists of seven steps: Reveal, Participate, Explore, Explain, Elaborate, Evaluate and Extend. According to past studies, 7E model is more effective in developing students than traditional learning models.
Study NCT06504082 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Letrozole
Description: Patients in the MTX + letrozole group received letrozole tablets (Femara 2.5 mg) once daily for ten days starting from the day of MTX administration.
Study NCT06504082 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate
Description: After confirming the diagnosis of tubal ectopic pregnancy, each patient will receive a single dose of intramuscular MTX (50 mg/m² MTX) on the same day
Study NCT06691815 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Triptorelin (GnRH agonists)
Description: 1. Triptorelin test. A baseline blood sample will be taken to determine LH, FSH, Estradiol/Testosterone, AMH, and Inhibin B. Then, Triptorelin Acetate 100 ug/m² of body surface area will be administered subcutaneously, maximum dose 0.1 mg (Decapeptyl Daily prefilled syringe of 0.1 mg for subcutaneous administration. Three hours later, a new sample will be taken to determine LH and FSH. The patient may return home and lead a normal life. An appointment will be made the following day to perform the last sample of this test 24 hours after the subcutaneous administration of Triptorelin Acetate, with the determination of LH, FSH, Estradiol/Testosterone, and Inhibin B.~2. GnRH Infusion: This consists of determining LH and FSH in baseline blood samples, 15, 30, 45, 60 and 120 minutes after slow infusion of GnRH. GnRH 0.83 μg/min during the 120 minutes that the study lasts (Luteoliberin 100 μg)
Study NCT06690697 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS004
Description: 200 mg, ivdrip, D1, Q3W, each 21 days as a treatment cycle
Study NCT06690697 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: 240 mg, ivdrip, D1, Q3W, each 21 days as a treatment cycle
Study NCT06690697 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Axitinib
Description: 5 mg, po, bid, each 21 days as a treatment cycle
Study NCT06690697 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sorafenib
Description: 0.4 g, po, bid, each 21 days as a treatment cycle
Study NCT06300619 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pilates+4
Description: 12 weeks of seated Pilates twice weekly. In weeks 1-3, participants receive training on hip and shoulder cuff activation. This occurs through active isometric pressure on the stabilizing limb (not the moving limb during a Pilates movement) for 3 seconds at 30% strength using the participants' own hand (e.g., pressure on the outside of the knee with knee pressing against hand) prior to engaging in each exercise. Following the first 3 weeks, participants in the Pilates+4 group engage in the same Pilates protocol as the comparator group, however, they receive 4-quadrant cues for hip and shoulder cuff activation as they learned in weeks 1-3.
Study NCT06694740 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interferon Gamma 1-b
Description: interferon gamma-1b 2 X 106 IU, injectable solution. Subcutaneous injection every 24 hours for 3 consecutive days (3 total injections)
Study NCT06694740 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients randomized to the placebo arm will receive saline injectable solution. Subcutaneous injection every 24 hours for 3 consecutive days (3 total injections)
Study NCT06300619 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pilates
Description: 12 weeks of seated Pilates twice weekly. 18 exercises standard in Pilates instruction will be provided with standard Pilates cues (i.e., core activation, cuing the moving limb, breathing synchronization).
Study NCT06695338 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Guided Bone Regeneration (Submerged)
Description: Guided Bone Regeneration by means of bone xenograft and collagen membrane (submerged approach)
Study NCT06695338 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Guided Bone Regeneration (Non-submerged)
Description: Guided Bone Regeneration by means of bone xenograft and collagen membrane (Non submerged Approach)
Study NCT06695611 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Increase systolic blood pressure
Description: To increase systolic blood pressure, treating physicians can consider the following options:~1. Withdraw blood pressure medications, reducing dose of medications that are not indicated for other reasons, or down titrate medication.~2. Increase estimated dry weight (EDW) by 0.5 kg increments if the participant is hypovolemic or euvolemic
Study NCT06695611 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Increase systolic blood pressure
Description: To increase systolic blood pressure, treating physicians can consider the following options:~1. Withdraw blood pressure medications, reducing dose of medications that are not indicated for other reasons, or down titrate medication.~2. Increase estimated dry weight (EDW) by 0.5 kg increments if the participant is hypovolemic or euvolemic
Study NCT06695611 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Decrease systolic blood pressure
Description: To decrease SBP, treating physicians can consider the following options:~1. Adjust blood pressure medications. This could be accomplished by increasing the dose of current medications, and/or adding an additional medication class. Choice of medication will be dependent on current medications, contraindications, age, comorbidities, and cardiovascular indications. Adherence to blood pressure medications should be reviewed.~2. Reduce EDW by 0.1 - 0.5 kg~3. Reduce sodium levels. This could be accomplished through a reduction in dietary sodium intake to \<2 gm/day and fluid intake to \<1.5 L per day. Adherence to dietary sodium restrictions should be reviewed with the participant~4. Extend dialysis time or adding an additional dialysis session if needed to achieve target dry weight
Study NCT06695611 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Decrease systolic blood pressure
Description: To decrease SBP, treating physicians can consider the following options:~1. Adjust blood pressure medications. This could be accomplished by increasing the dose of current medications, and/or adding an additional medication class. Choice of medication will be dependent on current medications, contraindications, age, comorbidities, and cardiovascular indications. Adherence to blood pressure medications should be reviewed.~2. Reduce EDW by 0.1 - 0.5 kg~3. Reduce sodium levels. This could be accomplished through a reduction in dietary sodium intake to \<2 gm/day and fluid intake to \<1.5 L per day. Adherence to dietary sodium restrictions should be reviewed with the participant~4. Extend dialysis time or adding an additional dialysis session if needed to achieve target dry weight